author-photo

Mario Mandalà

University of Perugia

18

Papers

49

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?

2021 American Journal of Clinical Dermatology
Show All
- Source
- Cite
- Save
Citations (1)
A case of sudden brain metastases progression after temporary targeted therapy discontinuation: when to regret a drug holiday.

2021 Melanoma Research
Show All
- Source
- Cite
- Save
Citations (0)
Corrigendum to 'Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)' [European Journal of Cancer 152 (2021) 116-128].

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (12)
Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Colorectal cancer and cardiovascular diseases: Are we closing the gap between knowledge and action?

2021 European Journal of Internal Medicine
- Mario Mandalà
- Fausto Roila
Show All
- Source
- Cite
- Save
Citations (0)
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.

2021 Gastric Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Vascular events with immune checkpoint inhibitors in melanoma or non-small cell lung cancer: A systematic review and meta-analysis.

2021 Cancer Treatment Reviews
Show All
- Source
- Cite
- Save
Citations (0)
1684P Cardiovascular events with immune checkpoint inhibitors in melanoma or NSCLC: A systematic review and meta-analysis

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)